{"a":[{"_":"Novo escalates Lilly false advertising suit with planned bid to halt comparative ads","$":{"href":"/marketing/novo-turns-heat-lilly-false-advertising-suit-seeking-preliminary-injunction-stop-rivals","hreflang":"en"}}]}

Summary

Novo Nordisk is escalating its false advertising lawsuit against Eli Lilly by seeking a preliminary injunction to halt Lilly's comparative ad campaigns that reference what Novo claims are outdated clinical trials comparing Lilly's drugs to Novo's Ozempic and Wegovy.